Full text is available at the source.
Abstract
Chronic sleep restriction (SR) leads to significant cognitive deficits and disrupts the localization of aquaporin-4 (AQP4) in the brain.
- SR impairs glymphatic clearance of toxic metabolites, which may contribute to brain dysfunction.
- Melatonin (Mel) treatment improves cognitive function and restores AQP4 polarity in mice subjected to SR.
- Mel enhances glymphatic transport and reduces levels of amyloid-beta and phosphorylated tau in the hippocampus of SR mice.
- Melatonin decreases glial cell activation, pro-inflammatory cytokine production, and synaptic protein loss associated with SR.
- The protective effects of Mel against SR-induced brain alterations are diminished in mice lacking AQP4.
- Mel activates the vitamin D receptor, leading to increased expression of DTNA, which helps restore AQP4 polarization during chronic SR.
Simplified